Proyecto
 (2013)

A phase 3 randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of BMS-188667 (Abatacept) or placebo on a background of Mycophenolate Mofetil (MMF) and corticosteroids in subjects with active class III or IV lupus nephritis.